{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:39:28Z","timestamp":1767980368193,"version":"3.49.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00823","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T04:23:18Z","timestamp":1525407798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Antibacterial Efficacy of Polysaccharide Capped Silver Nanoparticles Is Not Compromised by AcrAB-TolC Efflux Pump"],"prefix":"10.3389","volume":"9","author":[{"given":"Mitali","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harapriya","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.0900168","article-title":"Efflux pumps of Gram-negative bacteria: What they do, how they do it, with what and how to deal with them.","volume":"4","author":"Amaral","year":"2013","journal-title":"Front. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-017-3809-7","article-title":"Low concentrations of silver nanoparticles have a beneficial effect on wound healing in vitro.","volume":"19","author":"Ambro\u017eov\u00e1","year":"2017","journal-title":"J. Nanoparticle Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"40 Microbiology:a centenary perspective 1966 antibiotic susceptibility testing by a standardized single disk method.","volume":"45","author":"Bauer","year":"1966","journal-title":"Am. J. Clin. Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jac\/dku380","article-title":"Expression of homologous RND efflux pump genes is dependent upon AcrB expression: implications for efflux and virulence inhibitor design.","volume":"70","author":"Blair","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America.","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1039\/C2RA21912C","article-title":"A growth kinetic study of ultrafine monodispersed silver nanoparticles.","volume":"3","author":"Chandni","year":"2013","journal-title":"RSC Adv."},{"key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.addr.2014.08.004","article-title":"Metal nanobullets for multidrug resistant bacteria and biofilms.","volume":"78","author":"Chen","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12899","DOI":"10.1039\/C4RA15382K","article-title":"Copper nanoparticles as an efflux pump inhibitor to tackle drug resistant bacteria.","volume":"5","author":"Christena","year":"2015","journal-title":"RSC Adv."},{"key":"B9","year":"2016","journal-title":"M100S: Performance Standards for Antimicrobial Susceptibility Testing."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00392","article-title":"Enterobacter aerogenes and Enterobacter cloacae; Versatile bacterial pathogens confronting antibiotic treatment.","volume":"6","author":"Davin-Regli","year":"2015","journal-title":"Front. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1128\/AAC.46.8.2668","article-title":"Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae.","volume":"46","author":"Dibrov","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature13205","article-title":"Structure of the AcrAB-TolC multidrug efflux pump.","volume":"509","author":"Du","year":"2015","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.nano.2015.11.016","article-title":"Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity.","volume":"12","author":"Dur\u00e1n","year":"2016","journal-title":"Nanomedicine"},{"key":"B14","first-page":"114","article-title":"Enterobacter infections.","volume":"7","author":"Fraser","year":"2010","journal-title":"J. WebM D"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1164\/rccm.200504-613PP","article-title":"The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.","volume":"172","author":"Gelperina","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/0-387-30746-x_9","article-title":"The genus Enterobacter.","volume":"6","author":"Grimont","year":"2006","journal-title":"Prokaryotes"},{"key":"B17","article-title":"Impacts of silver nanoparticles on bacterial multidrug efflux pump.","volume":"27","author":"Gui","year":"2013","journal-title":"FASEB J."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-017-2222-6","article-title":"Nanoparticles as efflux pump and biofilm inhibitor to rejuvenate bactericidal effect of conventional antibiotics.","volume":"12","author":"Gupta","year":"2017","journal-title":"Nanoscale Res. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"95888","DOI":"10.1039\/c6ra16086g","article-title":"Sensing of tryptophan by a non-toxic cobalt(II) complex.","volume":"6","author":"Jana","year":"2016","journal-title":"RSC Adv."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01586-16","article-title":"Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application.","volume":"8","author":"Kerantzas","year":"2017","journal-title":"mBio"},{"key":"B21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nano.2006.12.001","article-title":"Antimicrobial effects of silver nanoparticles.","volume":"3","author":"Kim","year":"2007","journal-title":"Nanomedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nano.2015.10.015","article-title":"Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer.","volume":"12","author":"Kov\u00e1cs","year":"2016","journal-title":"Nanomedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents.","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-44890-9_2","article-title":"\u201cAg\/TiO2 (Metal\/Metal Oxide) core shell nanoparticles for biological applications,\u201d in","author":"Mangalaraj","year":"2017","journal-title":"Recent Trends in Materials Science and Applications"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01559","article-title":"Editorial: Alternative therapeutics against MDR bacteria - \u201cFighting the epidemic of antibiotic resistance.\u201d","volume":"7","author":"Martins","year":"2016","journal-title":"Front. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2217\/fmb.12.61","article-title":"Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance.","volume":"7","author":"Mezzatesta","year":"2012","journal-title":"Future Microbiol."},{"key":"B28","author":"Oldenburg","year":"2012","journal-title":"Silver Nanoparticles: Properties and Applications. Sigma-Aldrich."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance.","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens.","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/AAC.05509-11","article-title":"Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae.","volume":"56","author":"P\u00e9rez","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.19.2.382","article-title":"Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.","volume":"19","author":"Piddock","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/jac\/dki171","article-title":"Efflux-mediated antimicrobial resistance.","volume":"56","author":"Poole","year":"2005","journal-title":"J Antimicrob Chemother."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00282","article-title":"Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.","volume":"6","author":"Rangel-Vega","year":"2015","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1088\/2043-6254\/aa5983","article-title":"Green synthesis of silver nanoparticles with antibacterial activities using aqueous Eriobotrya japonica leaf extract.","volume":"80","author":"Rao","year":"2017","journal-title":"Adv. Nat. Sci. Nanosci. Nanotechnol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1046\/j.1365-2958.2003.03531.x","article-title":"Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein.","volume":"48","author":"Rosenberg","year":"2003","journal-title":"Mol. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jac\/dkt352","article-title":"Regulation of acrAB expression by cellular metabolites in Escherichia coli.","volume":"69","author":"Ruiz","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3155-2-3","article-title":"Applications of nanoparticles in biology and medicine.","volume":"2","author":"Salata","year":"2004","journal-title":"J. Nanobiotechnol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/CMR.10.2.220","article-title":"Enterobacter spp.: Pathogens poised to flourish at the turn of the century.","volume":"10","author":"Sanders","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/srep24929","article-title":"Polysaccharide-capped silver Nanoparticles inhibit biofilm formation and eliminate multi-drug-resistant bacteria by disrupting bacterial cytoskeleton with reduced cytotoxicity towards mammalian cells.","volume":"6","author":"Sanyasi","year":"2016","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery.","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.05.090","article-title":"Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations.","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria.","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chembiol.2011.02.011","article-title":"Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC.","volume":"18","author":"Tikhonova","year":"2011","journal-title":"Chem. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2147\/IJN.S21729","article-title":"Selenium nanoparticles inhibit Staphylococcus aureus growth.","volume":"6","author":"Tran","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"B46","year":"2014","journal-title":"ANTIMICROBIAL RESISTANCE Global Report on Surveillance 2014."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00542","article-title":"Engineered bacteriophage lysins as novel anti-infectives.","volume":"5","author":"Yang","year":"2014","journal-title":"Front. Microbiol."},{"key":"B48","first-page":"32","article-title":"Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.","volume":"62","author":"Yue","year":"2008","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2217\/fmb.09.62.Multicomponent","article-title":"Multicomponent drug efflux complexes: architecture and mechanism of assembly.","volume":"4","author":"Zgurskaya","year":"2009","journal-title":"Future Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T13:23:19Z","timestamp":1571318599000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":49,"alternative-id":["10.3389\/fmicb.2018.00823"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00823","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"article-number":"823"}}